Advertisement
The webcast can be accessed through the Investors page of deCODE'swebsite, http://www.decode.com, or through http://www.earnings.com. Pleaselog in to the webcast 15 minutes prior to the scheduled start of the call.The call will be archived for at least a week on each site. For those unableto listen to the webcast because of company firewall or other issues, adigitized audio replay will also be available by telephone from approximately10am EDT on Tuesday, August 11 and for one week thereafter. The dial-inreplay numbers are: 1-800-475-6701 in the U.S., and +1-320-365-3844 for thosecalling from outside the U.S. The access code is 111342.
Advertisement
Any statements contained in this presentation that relate to futureplans, events or performance are forward-looking statements within themeaning of the Private Securities Litigation Reform Act of 1995. Theseforward-looking statements are subject to a number of risks and uncertaintiesthat could cause actual results, and the timing of events, to differmaterially from those described in the forward-looking statements. Theserisks and uncertainties include, among others, those relating to our abilityto obtain sufficient financing to continue as a going concern, our ability todevelop and market diagnostic products, the level of third partyreimbursement for our products, risks related to preclinical and clinicaldevelopment of pharmaceutical products, including the identification ofcompounds and the completion of clinical trials, our ability to formcollaborative relationships, the effect of government regulation and theregulatory approval processes, market acceptance, our ability to obtain andprotect intellectual property rights for our products, dependence oncollaborative relationships, the effect of competitive products, industrytrends and other risks identified in deCODE's filings with the Securities andExchange Commission, including, without limitation, the risk factorsidentified in our most recent Annual Report on Form 10-K and any updates tothose risk factors filed from time to time in our Quarterly Reports on Form10-Q or Current Reports on Form 8-K. deCODE undertakes no obligation toupdate or alter these forward-looking statements as a result of newinformation, future events or otherwise.Contacts: deCODE genetics Gisli Arnason +354-570-1825 [email protected]
SOURCE deCODE genetics Inc.
